F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder by BY VIRGINIA HUGHES

This entry was posted in Health Weight Watchers and tagged Health NYT on by

Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar.

Published: August 12, 2021 at 08:44PM

from NYT Health https://ift.tt/3AG4mlt